The story of Sildenafil offers a complex case study for investors eyeing drug companies. While early sales were explosive, present patent expiry and the emergence of generic versions have severely affected earnings. https://shaniaoixm526664.kylieblog.com/41569395/sildenafil-and-pharma-a-risky-investment